Company: CYTK
Filing Date: 2025-03-31
Form Type: PRE 14A
Source: 0001140361-25-011212
Chunk: 124

Company: CYTOKINETICS INC
Filing Date: 2025-03-31
Form: PRE 14A
Chunk 124
---
 9 of the Plan. (ee) “Performance Period” means any Fiscal Year or such other period as determined by the Administrator in its sole discretion. (ff) “Performance Share” or “Performance Unit” means an Award granted to a Participant pursuant to Section 8.

| A-12 |     | Cytokinetics, Inc.|2025 Proxy Statement |

TABLE OF CONTENTS APPENDIX A (gg) “Period of Restriction” means the period during which the transfer of shares of Restricted Stock are subject to restrictions and therefore, the shares of Restricted Stock are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the Administrator. (hh) “Plan” means this Amended and Restated 2004 Equity Incentive Plan. (ii) “Restricted Stock” means Shares issued pursuant to a Restricted Stock Award under Section 6 of the Plan, or issued pursuant to the early exercise of an Option. (jj) “Restricted Stock Unit” shall mean a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section 7. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company. (kk) “Service Provider” means an Employee, Director or Consultant. (ll) “Share” means a share of the Stock, as adjusted in accordance with Section 12 of the Plan. (mm) “Stock” means the Common Stock of the Company. (nn) “Stock Appreciation Right” or “SAR” means an Award, granted alone or in connection with an Option, that pursuant to Section 5 is designated as a SAR. (oo) “Subsidiary” means a “subsidiary corporation” , whether now or hereafter existing, as defined in Section 424(f) of the Code. (pp) “Ten Percent Stockholder” means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate. * * * *

| Cytokinetics, Inc.|2025 Proxy Statement |     | A-13 |

TABLE OF CONTENTS APPENDIX B CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CYTOKINETICS, INCORPORATED